Drugs that suppress TSH or cause central hypothyroidism

被引:161
作者
Haugen, Bryan R. [1 ]
机构
[1] Univ Colorado Denver, Sch Med, Dept Med, Div Endocrinol Metab & Diabet, Aurora, CO 80045 USA
关键词
TSH; central hypothyroidism; medications; thyroid function; glucocorticoids; dopamine; somatostatin; rexinoids; THYROTROPIN-RELEASING-HORMONE; CLINICAL-RESEARCH CENTER; THYROID-FUNCTION; ORAL BEXAROTENE; SOMATOSTATIN RECEPTORS; LUTEINIZING-HORMONE; SECRETION; RAT; GLUCOCORTICOIDS; OCTREOTIDE;
D O I
10.1016/j.beem.2009.08.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Many different drugs affect thyroid function. Most of these drugs act at the level of the thyroid in patients with normal thyroid function. or at the level of thyroid hormone absorption or metabolism in patients requiring exogenous levothyroxine. A small subset of medications including glucocorticoids. dopamine agonists. somatostatin analogues and rexinoids affect thyroid function through suppression of TSH in the thyrotrope or hypothalamus Fortunately. most of these medications do not cause clinically evident central hypothyroidism A newer class Of nuclear hormone receptors agonists, called rexinoids, cause clinically significant central hypothyroidism in most patients and dopamine agonists may exacerbate 'hypothyroidism' in patients with non-thyroidal illness In this review, we explore mechanisms governing TSH suppression of these drugs and the clinical relevance of these effects. (C) 2009 Elsevier Ltd All rights reserved
引用
收藏
页码:793 / 800
页数:8
相关论文
共 46 条
  • [21] STUDIES ON THE CONDITIONS DETERMINING THE INHIBITORY EFFECT OF SOMATOSTATIN ON ADRENOCORTICOTROPIN, PROLACTIN AND THYROTROPIN RELEASE BY CULTURED RAT PITUITARY-CELLS
    LAMBERTS, SW
    ZUYDERWIJK, J
    DENHOLDER, F
    VANKOETSVELD, P
    HOFLAND, L
    [J]. NEUROENDOCRINOLOGY, 1989, 50 (01) : 44 - 50
  • [22] DOPAMINE STIMULATES RELEASE OF THYROTROPIN-RELEASING-HORMONE FROM PERFUSED INTACT RAT HYPOTHALAMUS VIA HYPOTHALAMIC D2-RECEPTORS
    LEWIS, BM
    DIEGUEZ, C
    LEWIS, MD
    SCANLON, MF
    [J]. JOURNAL OF ENDOCRINOLOGY, 1987, 115 (03) : 419 - 424
  • [23] THE EFFECT OF SMS-201-995, A LONG-ACTING SOMATOSTATIN ANALOG, ON ANTERIOR-PITUITARY FUNCTION IN HEALTHY MALE-VOLUNTEERS
    LIGHTMAN, SL
    FOX, P
    DUNNE, MJ
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1986, 21 : 84 - 95
  • [24] Mechanism of selective retinoid X receptor agonist-induced hypothyroidism in the rat
    Liu, S
    Ogilvie, KM
    Klausing, K
    Lawson, MA
    Jolley, D
    Li, DM
    Bilakovics, J
    Pascual, B
    Hein, N
    Urcan, M
    Leibowitz, MD
    [J]. ENDOCRINOLOGY, 2002, 143 (08) : 2880 - 2885
  • [25] Different responses to chronic somatostatin analogues in patients with central hyperthyroidism
    Mannavola, D
    Persani, L
    Vannucchi, G
    Zanardelli, M
    Fugazzola, L
    Verga, U
    Facchetti, M
    Beck-Peccoz, P
    [J]. CLINICAL ENDOCRINOLOGY, 2005, 62 (02) : 176 - 181
  • [26] Central hypothyroidism with oxcarbazepine therapy
    Miller, J
    Carney, P
    [J]. PEDIATRIC NEUROLOGY, 2006, 34 (03) : 242 - 244
  • [27] NEUROENDOCRINE CONTROL OF THYROTROPIN SECRETION
    MORLEY, JE
    [J]. ENDOCRINE REVIEWS, 1981, 2 (04) : 396 - 436
  • [28] The novel somatostatin ligand (SOM230) regulates human and rat anterior pituitary hormone secretion
    Murray, RD
    Kim, K
    Ren, SG
    Lewis, I
    Weckbecker, G
    Bruns, C
    Melmed, S
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) : 3027 - 3032
  • [29] ROLE OF GLUCOCORTICOIDS IN REGULATION OF THYROID FUNCTION IN MAN
    NICOLOFF, JT
    FISHER, DA
    APPLEMAN, MD
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1970, 49 (10) : 1922 - +
  • [30] Activation of the retinoid X receptor suppresses appetite in the rat
    Ogilvie, KM
    Saladin, R
    Nagy, TR
    Urcan, MS
    Heyman, RA
    Leibowitz, MD
    [J]. ENDOCRINOLOGY, 2004, 145 (02) : 565 - 573